Most frequent molecular and immunohistochemical markers present in selected types of brain tumors

被引:11
作者
Richterova, Romana [1 ,2 ]
Jurecekova, Jana [1 ]
Evinova, Andrea [1 ]
Kolarovszki, Branislav [2 ]
Benco, Martin [2 ]
De Riggo, Julius [2 ]
Sutovsky, Juraj [2 ]
Mahmood, Silvia [1 ]
Racay, Peter [1 ]
Dobrota, Dusan [1 ]
机构
[1] Comenius Univ, Jessenius Fac Med, Dept Med Biochem, Martin, Slovakia
[2] Comenius Univ, Dept Neurosurg, Univ Hosp Martin, Jessenius Fac Med, Martin, Slovakia
关键词
Brain tumors; Glioma; Meningioma; Genetic alteration; ANAPLASTIC OLIGODENDROGLIAL TUMORS; NEWLY-DIAGNOSED GLIOBLASTOMA; S-TRANSFERASE POLYMORPHISMS; GENE-EXPRESSION; INTRACRANIAL EPENDYMOMA; PROGNOSTIC-SIGNIFICANCE; RADIATION-THERAPY; SIGNALING PATHWAY; IDH1; MUTATIONS; GROWTH-FACTORS;
D O I
10.4149/gpb_2014007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumors of brain tissue and meninges create a heterogeneous group with various biological behavior, therapy management and differing prognosis. Some of these do not require treatment, some can be cured by surgery and some are rapidly fatal despite treatment. Despite huge progress in tumor research, innovations in diagnostic tools and therapy, prognosis remains, in case of malignant tumor types, very serious. There has been an increased understanding of molecular abnormalities occurring in primary brain tumors. Genome-wide analyses of tumors have improved the knowledge in tumor biology. The aim of the research is to explain the oncogenesis features thus leading to the use of new therapeutic modalities in order to prolong survival rate of patients and at the same time providing satisfactory life quality. This article offers a short review of the basic genetic alterations present with some histological types of brain tumors.
引用
收藏
页码:259 / 279
页数:21
相关论文
共 164 条
[1]   Survivin Expression in Medulloblastoma: A Possible Marker for Survival [J].
Abdel-Aziz, Azza ;
Mohamed, Mie Ali Ali ;
Akl, Fatma Mohamed Farouk ;
Taha, Ahmed Nageeb M. .
PATHOLOGY & ONCOLOGY RESEARCH, 2013, 19 (03) :413-419
[2]  
Al-Salameh A, 2010, J ENDOCRINOL INVEST, V33, P353, DOI [10.3275/6813, 10.1007/BF03346599]
[3]   Mechanisms of Local Immunoresistance in Glioma [J].
Albesiano, Emilia ;
Han, James E. ;
Lim, Michael .
NEUROSURGERY CLINICS OF NORTH AMERICA, 2010, 21 (01) :17-+
[4]  
[Anonymous], CBTRUS STAT REP PRIM
[5]  
Backer-Grondahl T, 2012, INT J CLIN EXP PATHO, V5, P231
[6]   Analysis of the IDH1 codon 132 mutation in brain tumors [J].
Balss, Joerg ;
Meyer, Jochen ;
Mueller, Wolf ;
Korshunov, Andrey ;
Hartmann, Christian ;
von Deimling, Andreas .
ACTA NEUROPATHOLOGICA, 2008, 116 (06) :597-602
[7]  
Bhagavathi S, 2008, ARCH PATHOL LAB MED, V132, P1830, DOI 10.1043/1543-2165-132.11.1830
[8]   A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease [J].
Bhowmick, DA ;
Zhuang, ZP ;
Wait, SD ;
Weil, RJ .
CANCER RESEARCH, 2004, 64 (04) :1220-1223
[9]   Absence of AKT1 Mutations in Glioblastoma [J].
Bleeker, Fonnet E. ;
Lamba, Simona ;
Zanon, Carlo ;
van Tilborg, Angela A. ;
Leenstra, Sieger ;
Troost, Dirk ;
Hulsebos, Theo ;
Vandertop, W. Peter ;
Bardelli, Alberto .
PLOS ONE, 2009, 4 (05)
[10]   Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium [J].
Bondy, Melissa L. ;
Scheurer, Michael E. ;
Malmer, Beatrice ;
Barnholtz-Sloan, Jill S. ;
Davis, Faith G. ;
Il'Yasova, Dora ;
Kruchko, Carol ;
McCarthy, Bridget J. ;
Rajaraman, Preetha ;
Schwartzbaum, Judith A. ;
Sadetzki, Siegal ;
Schlehofer, Brigitte ;
Tihan, Tarik ;
Wiemels, Joseph L. ;
Wrensch, Margaret ;
Buffler, Patricia A. .
CANCER, 2008, 113 (07) :1953-1968